NO762311L - - Google Patents
Info
- Publication number
- NO762311L NO762311L NO762311A NO762311A NO762311L NO 762311 L NO762311 L NO 762311L NO 762311 A NO762311 A NO 762311A NO 762311 A NO762311 A NO 762311A NO 762311 L NO762311 L NO 762311L
- Authority
- NO
- Norway
- Prior art keywords
- benzisothiazole
- derivative
- agent according
- alkyl
- radical
- Prior art date
Links
- CSNIZNHTOVFARY-UHFFFAOYSA-N 1,2-benzothiazole Chemical class C1=CC=C2C=NSC2=C1 CSNIZNHTOVFARY-UHFFFAOYSA-N 0.000 claims description 26
- -1 alkyl radical Chemical class 0.000 claims description 16
- 125000004432 carbon atom Chemical group C* 0.000 claims description 13
- 125000000217 alkyl group Chemical group 0.000 claims description 10
- 125000005843 halogen group Chemical group 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 150000003254 radicals Chemical class 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 125000001302 tertiary amino group Chemical group 0.000 claims description 3
- JWEGXCBMAYWJHA-UHFFFAOYSA-N 1-(6-nitro-1-oxo-3h-1,2-benzothiazol-2-yl)ethanone Chemical group C1=C([N+]([O-])=O)C=C2S(=O)N(C(=O)C)CC2=C1 JWEGXCBMAYWJHA-UHFFFAOYSA-N 0.000 claims description 2
- YBJXQKHPLFCUPH-UHFFFAOYSA-N 2-butyl-3h-1,2-benzothiazole 1-oxide Chemical group C1=CC=C2S(=O)N(CCCC)CC2=C1 YBJXQKHPLFCUPH-UHFFFAOYSA-N 0.000 claims description 2
- FISULHBAQJWFKY-UHFFFAOYSA-N 2-propan-2-yl-1,2-benzothiazole-3-thione Chemical group C1=CC=C2C(=S)N(C(C)C)SC2=C1 FISULHBAQJWFKY-UHFFFAOYSA-N 0.000 claims description 2
- CADAVJPFTYSCTD-UHFFFAOYSA-N 2-propyl-1,2-benzothiazole-3-thione Chemical group C1=CC=C2C(=S)N(CCC)SC2=C1 CADAVJPFTYSCTD-UHFFFAOYSA-N 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 12
- 150000005840 aryl radicals Chemical group 0.000 claims 2
- JMXMHKNZVQBCFP-UHFFFAOYSA-N 1-(3-sulfanylidene-1,2-benzothiazol-2-yl)ethanone Chemical group C1=CC=C2C(=S)N(C(=O)C)SC2=C1 JMXMHKNZVQBCFP-UHFFFAOYSA-N 0.000 claims 1
- QRPKIDIBALJAQD-UHFFFAOYSA-N 2-(2-hydroxyethyl)-1,2-benzothiazole-3-thione Chemical group C1=CC=C2C(=S)N(CCO)SC2=C1 QRPKIDIBALJAQD-UHFFFAOYSA-N 0.000 claims 1
- BYIQDNUYNKFHJQ-UHFFFAOYSA-N 2-butyl-5-nitro-3h-1,2-benzothiazole 1-oxide Chemical group [O-][N+](=O)C1=CC=C2S(=O)N(CCCC)CC2=C1 BYIQDNUYNKFHJQ-UHFFFAOYSA-N 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 229940127234 oral contraceptive Drugs 0.000 claims 1
- 239000003539 oral contraceptive agent Substances 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 230000000694 effects Effects 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 230000001150 spermicidal effect Effects 0.000 description 8
- 235000015097 nutrients Nutrition 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- KANAPVJGZDNSCZ-UHFFFAOYSA-N 1,2-benzothiazole 1-oxide Chemical class C1=CC=C2S(=O)N=CC2=C1 KANAPVJGZDNSCZ-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000000934 spermatocidal agent Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 239000003433 contraceptive agent Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 229920000847 nonoxynol Polymers 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 230000019100 sperm motility Effects 0.000 description 3
- 239000000522 vaginal cream Substances 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 229960001950 benzethonium chloride Drugs 0.000 description 2
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 229940124558 contraceptive agent Drugs 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000000855 fungicidal effect Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000004899 motility Effects 0.000 description 2
- PDTFCHSETJBPTR-UHFFFAOYSA-N phenylmercuric nitrate Chemical compound [O-][N+](=O)O[Hg]C1=CC=CC=C1 PDTFCHSETJBPTR-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 229940044959 vaginal cream Drugs 0.000 description 2
- UZZCLESJSWOKLW-UHFFFAOYSA-N (6-nitro-1-oxo-3h-1,2-benzothiazol-2-yl)-phenylmethanone Chemical compound O=S1C2=CC([N+](=O)[O-])=CC=C2CN1C(=O)C1=CC=CC=C1 UZZCLESJSWOKLW-UHFFFAOYSA-N 0.000 description 1
- YJJMBWKVCPBJDJ-UHFFFAOYSA-N 1,2-benzothiazole-3-thione Chemical compound C1=CC=C2C(=S)NSC2=C1 YJJMBWKVCPBJDJ-UHFFFAOYSA-N 0.000 description 1
- NFZORMRYYVCWQM-UHFFFAOYSA-N 2-ethyl-1,2-benzothiazole-3-thione Chemical compound C1=CC=C2C(=S)N(CC)SC2=C1 NFZORMRYYVCWQM-UHFFFAOYSA-N 0.000 description 1
- MPBXKVDNCLWMQK-UHFFFAOYSA-N 2-methyl-5-nitro-3h-1,2-benzothiazole 1-oxide Chemical compound [O-][N+](=O)C1=CC=C2S(=O)N(C)CC2=C1 MPBXKVDNCLWMQK-UHFFFAOYSA-N 0.000 description 1
- SLRMQYXOBQWXCR-UHFFFAOYSA-N 2154-56-5 Chemical group [CH2]C1=CC=CC=C1 SLRMQYXOBQWXCR-UHFFFAOYSA-N 0.000 description 1
- IYFOEVOXKZUQPJ-UHFFFAOYSA-N 5-chloro-1,2-benzothiazol-3-one Chemical compound C1=C(Cl)C=C2C(O)=NSC2=C1 IYFOEVOXKZUQPJ-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical group [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940027983 antiseptic and disinfectant quaternary ammonium compound Drugs 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- DMSMPAJRVJJAGA-UHFFFAOYSA-N benzo[d]isothiazol-3-one Chemical compound C1=CC=C2C(=O)NSC2=C1 DMSMPAJRVJJAGA-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 230000009087 cell motility Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 230000001408 fungistatic effect Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical group 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 239000007970 homogeneous dispersion Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229940096825 phenylmercury Drugs 0.000 description 1
- DCNLOVYDMCVNRZ-UHFFFAOYSA-N phenylmercury(.) Chemical compound [Hg]C1=CC=CC=C1 DCNLOVYDMCVNRZ-UHFFFAOYSA-N 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000011493 spray foam Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006216 vaginal suppository Substances 0.000 description 1
- 239000000003 vaginal tablet Substances 0.000 description 1
- 235000012773 waffles Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/14—Topical contraceptives and spermacides
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Debugging And Monitoring (AREA)
- Separation Of Suspended Particles By Flocculating Agents (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT25051/75A IT1039699B (it) | 1975-07-03 | 1975-07-03 | Composizione spermicida a base di derivati benzisotiazolici |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO762311L true NO762311L (US06265458-20010724-C00018.png) | 1977-01-04 |
Family
ID=11215541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO762311A NO762311L (US06265458-20010724-C00018.png) | 1975-07-03 | 1976-07-02 |
Country Status (12)
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU522792B2 (en) * | 1977-07-19 | 1982-06-24 | Fisons Plc | Pressure pack formulation |
| DE3041036A1 (de) * | 1980-10-31 | 1982-06-09 | A. Nattermann & Cie GmbH, 5000 Köln | Verwendung von benzisothiazolen |
| JPS58177982A (ja) * | 1982-04-09 | 1983-10-18 | Green Cross Corp:The | ベンズイソチアゾリン誘導体及び抗白癬菌剤 |
| JPS58177915A (ja) * | 1982-04-12 | 1983-10-18 | Green Cross Corp:The | 抗血栓剤 |
| JPS6086541U (ja) * | 1983-11-22 | 1985-06-14 | 株式会社幸袋工作所 | コ−クス炉々蓋掃除装置 |
| JPS6093745U (ja) * | 1983-12-02 | 1985-06-26 | 株式会社幸袋工作所 | コ−クス炉々蓋掃除装置 |
| CA1340759C (en) * | 1988-07-01 | 1999-09-21 | James P. Albarella | Isobenzothiazolone chromogenic thiol indicators and their derivatives |
| US5620997A (en) * | 1995-05-31 | 1997-04-15 | Warner-Lambert Company | Isothiazolones |
| US6001863A (en) * | 1996-11-26 | 1999-12-14 | Warner-Lambert Company | Isothiazolones |
| US6399593B1 (en) | 1999-05-04 | 2002-06-04 | Wyeth | Cyclic regimens using cyclic urea and cyclic amide derivatives |
| US6329416B1 (en) | 1999-05-04 | 2001-12-11 | American Home Products Corporation | Combination regimens using 3,3-substituted indoline derivatives |
| US6358948B1 (en) | 1999-05-04 | 2002-03-19 | American Home Products Corporation | Quinazolinone and benzoxazine derivatives as progesterone receptor modulators |
| US6380178B1 (en) | 1999-05-04 | 2002-04-30 | American Home Products Corporation | Cyclic regimens using cyclocarbamate and cyclic amide derivatives |
| US6380235B1 (en) | 1999-05-04 | 2002-04-30 | American Home Products Corporation | Benzimidazolones and analogues |
| US6407101B1 (en) | 1999-05-04 | 2002-06-18 | American Home Products Corporation | Cyanopyrroles |
| US6391907B1 (en) * | 1999-05-04 | 2002-05-21 | American Home Products Corporation | Indoline derivatives |
| US6358947B1 (en) | 1999-05-04 | 2002-03-19 | American Home Products Corporation | Tetracyclic progesterone receptor modulator compounds and methods |
| US6319912B1 (en) | 1999-05-04 | 2001-11-20 | American Home Products Corporation | Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides |
| US6462032B1 (en) | 1999-05-04 | 2002-10-08 | Wyeth | Cyclic regimens utilizing indoline derivatives |
| US6306851B1 (en) | 1999-05-04 | 2001-10-23 | American Home Products Corporation | Cyclocarbamate and cyclic amide derivatives |
| US6444668B1 (en) | 1999-05-04 | 2002-09-03 | Wyeth | Combination regimens using progesterone receptor modulators |
| US6417214B1 (en) * | 1999-05-04 | 2002-07-09 | Wyeth | 3,3-substituted indoline derivatives |
| US6509334B1 (en) * | 1999-05-04 | 2003-01-21 | American Home Products Corporation | Cyclocarbamate derivatives as progesterone receptor modulators |
| US6355648B1 (en) | 1999-05-04 | 2002-03-12 | American Home Products Corporation | Thio-oxindole derivatives |
| US6339098B1 (en) | 1999-05-04 | 2002-01-15 | American Home Products Corporation | 2,1-benzisothiazoline 2,2-dioxides |
| US6369056B1 (en) | 1999-05-04 | 2002-04-09 | American Home Products Corporation | Cyclic urea and cyclic amide derivatives |
| US6498154B1 (en) | 1999-05-04 | 2002-12-24 | Wyeth | Cyclic regimens using quinazolinone and benzoxazine derivatives |
| US6423699B1 (en) | 1999-05-04 | 2002-07-23 | American Home Products Corporation | Combination therapies using benzimidazolones |
| UA73119C2 (en) * | 2000-04-19 | 2005-06-15 | American Home Products Corpoir | Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors |
| US6696473B2 (en) * | 2001-12-21 | 2004-02-24 | X-Ceptor Therapeutics, Inc. | Heterocyclic modulators of nuclear receptors |
| WO2003059884A1 (en) | 2001-12-21 | 2003-07-24 | X-Ceptor Therapeutics, Inc. | Modulators of lxr |
| US7482366B2 (en) | 2001-12-21 | 2009-01-27 | X-Ceptor Therapeutics, Inc. | Modulators of LXR |
| US20050025847A1 (en) * | 2003-02-26 | 2005-02-03 | Program For Appropriate Technology In Health | Microbicidal compositions and method of use |
| WO2004105662A1 (en) * | 2003-05-23 | 2004-12-09 | Program For Appropriate Technology In Health | Microbicidal compositions and methods of use |
| CN101076585A (zh) * | 2003-08-14 | 2007-11-21 | 生物平衡公司 | 细菌株系、包括该细菌株系的组合物和其益生菌用途 |
| UA93354C2 (ru) | 2004-07-09 | 2011-02-10 | Гилиад Сайенсиз, Инк. | Местный противовирусный препарат |
| CA2782441A1 (en) | 2009-12-01 | 2011-06-09 | Seprox Biotech, S.L. | Topical use of hydroxytyrosol and derivatives for the prevention of hiv infection |
| EP2546358A1 (en) | 2011-07-15 | 2013-01-16 | Laboratorios Del. Dr. Esteve, S.A. | Methods and reagents for efficient control of HIV progression |
| CN109503547B (zh) * | 2018-12-20 | 2021-03-16 | 江苏师范大学 | 苯并二硫环戊二烯衍生物的制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3012039A (en) * | 1958-03-14 | 1961-12-05 | Ici Ltd | 2-p-chlorobenzyl-1, 2-benzisothiazolone |
| GB848130A (en) * | 1958-03-14 | 1960-09-14 | Ici Ltd | Benzisothiazolones |
| GB861379A (en) * | 1958-03-14 | 1961-02-22 | Ici Ltd | Therapeutic compositions comprising 1:2-benzisothiazolone derivatives |
| CH395094A (de) * | 1960-03-24 | 1965-07-15 | Wander Ag Dr A | Verfahren zur Herstellung von 6-Chlor-benzisothiazolon |
| DE1147947B (de) * | 1961-07-25 | 1963-05-02 | Knoll Ag | Verfahren zur Herstellung neuer 1, 2-Benzisothiazolone |
| SE392103B (sv) * | 1970-04-27 | 1977-03-14 | Sherwin Williams Co | Sett att framstella 1,2-bensisotiazolin-3-oner |
-
1975
- 1975-07-03 IT IT25051/75A patent/IT1039699B/it active
-
1976
- 1976-06-28 IL IL49922A patent/IL49922A0/xx unknown
- 1976-06-28 US US05/700,115 patent/US4093730A/en not_active Expired - Lifetime
- 1976-06-28 GB GB26883/76A patent/GB1495909A/en not_active Expired
- 1976-06-28 FR FR7619570A patent/FR2315927A1/fr active Granted
- 1976-06-29 DE DE19762629018 patent/DE2629018A1/de not_active Withdrawn
- 1976-06-30 CA CA256,023A patent/CA1060345A/en not_active Expired
- 1976-07-02 SE SE7607597A patent/SE7607597L/xx not_active Application Discontinuation
- 1976-07-02 BE BE168608A patent/BE843745A/xx not_active IP Right Cessation
- 1976-07-02 NO NO762311A patent/NO762311L/no unknown
- 1976-07-02 DK DK298676A patent/DK298676A/da not_active Application Discontinuation
- 1976-07-03 JP JP51079410A patent/JPS527444A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| SE7607597L (sv) | 1977-01-04 |
| FR2315927B1 (US06265458-20010724-C00018.png) | 1979-05-04 |
| JPS527444A (en) | 1977-01-20 |
| DE2629018A1 (de) | 1977-01-27 |
| IT1039699B (it) | 1979-12-10 |
| US4093730A (en) | 1978-06-06 |
| FR2315927A1 (fr) | 1977-01-28 |
| CA1060345A (en) | 1979-08-14 |
| DK298676A (da) | 1977-01-04 |
| IL49922A0 (en) | 1976-08-31 |
| GB1495909A (en) | 1977-12-21 |
| BE843745A (fr) | 1977-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO762311L (US06265458-20010724-C00018.png) | ||
| CA1158559A (en) | Control of mastitis and compositions therefor | |
| Anderson et al. | Preclinical evaluation of sodium cellulose sulfate (Ushercell) as a contraceptive antimicrobial agent | |
| EP0168229A2 (en) | Pharmaceutical antifungal composition | |
| US4047930A (en) | Method of sterilizing male anthers | |
| WO2006087230A1 (de) | Verwendung von cdk ii inhibitoren zur fertilitätskontrolle | |
| EP0576425B1 (en) | Method for inactivating sperm | |
| AU4009499A (en) | N-acyl sarcosinates as glyphosate adjuvants | |
| US4602042A (en) | Contraceptive methods | |
| US6783767B2 (en) | Low temperature disinfectant/sterilant for medical devices and topical applications | |
| AU2007229268A1 (en) | Contraceptive composition | |
| US3008875A (en) | Neomycin and mirystyl-gamma-picolinium halide compositions | |
| DE69324393T2 (de) | Mittel auf Basis von Antiseptiken und ihre Verwendungen | |
| AT501545A1 (de) | Reinigungsmittel für kontaktlinsen | |
| White et al. | Complementary effects of propranolol and nonoxynol-9 upon human sperm motility | |
| NO872142L (no) | Stoff, farmasoeytisk eller kosmetisk blanding samt fremgangsmaater ved fremstilling derav. | |
| WO2002049633A2 (en) | Use of amidoamines to treat or prevent acanthamoeba and fungal infections | |
| US4277461A (en) | Vaginal contraceptive | |
| EP0076430B1 (en) | Compositions having antimicrobial activity | |
| Shubair et al. | Growth inhibition of Candida albicans and other medically important yeasts by vaginal contraceptive products | |
| AU776995B2 (en) | Carnitine analogues as topical, microbicidal spermicides | |
| EP0821584B1 (en) | 2,4-dichlorobenzyl alcohol and amylmetacresol against hiv infection | |
| Dzierzawski et al. | Embryotoxic effects of chlorfenvinphos and bromfenvinphos in laboratory animals | |
| IE48222B1 (en) | Ophthalmic compositions containing colchicine and vinblastine | |
| Brotherton | Assessment of spermicides by a stripping technique against human spermatozoa |